Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™ ...Middle East

JERSEY CITY, N.J., April 28, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans covering more than 100 million people. The agreement,...

Hence then, the article about celltrion usa signs agreement with express scripts for its therapy for autoimmune diseases including the first fda approved subcutaneous infliximab zymfentra was published today ( Monday 29/04/2024 - 02:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™ )

Also on site :

• Suspect in Mississippi synagogue fire laughed as he confessed to his dad, authorities say
• Fire crews and Hazmat teams responded to fire involving lithium ion batteries at Higuera Street facility
• No injuries reported after partial building collapse in the Bronx, officials say